Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
NRV information for non Boots products is calculated by the manufacturer
Phase 3 clinical trials are still underway, coming to a close in May 2026
It promotes muscle comfort by supporting cellular repair and minimising fatigue
Between January 2024 and June 2025, first-time prescribing increased at an average rate of 0.01 percentage points per month, a 239% gain over the period
Ir J Med Sci
Needleless technology significantly diminishes these events, making the treatment process safer for everyone involved
US$ 21.92
US$ 21.06
US$ 29.65
US$ 28.92
US$ 27.16
US$ 25.10
US$ 27.81
